Panchsheel Organics Limited (BOM:531726)

Market Cap	1.38B -38.2%
Revenue (ttm)	1.03B -6.7%
Net Income	120.40M -11.9%
EPS	9.14 -20.7%
Shares Out	13.17M
PE Ratio	11.46
Forward PE	n/a
Dividend	3.20 (3.06%)
Ex-Dividend Date	Feb 20, 2026

Volume	3,124
Average Volume	7,194
Open	103.35
Previous Close	105.50
Day's Range	103.20 - 108.00
52-Week Range	100.00 - 184.00
Beta	-0.55
RSI	40.71
Earnings Date	Feb 14, 2026

About Panchsheel Organics

Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Org...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 185
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531726

Financial Performance

In fiscal year 2025, Panchsheel Organics's revenue was 1.07 billion, an increase of 1.86% compared to the previous year's 1.05 billion. Earnings were 137.95 million, a decrease of -2.22%.